fda tirzepatide obesity grants fast track designation to tirzepatide, Eli Lilly's new type 2 diabetes drug, for treating Zepbound, Obesity Version of Eli

1.09]) (p = 0.05 for interaction)

Demand has been so high, both drugs are now listed in short supply on the Federal Drug Administrations drug shortage website

"These unlawful marketing and sales practices, including the use of Novo Nordisk trademarks in connection with these practices, have created a high risk of consumer confusion and deception as well as potential safety concerns," the company said in a June news release.

When researchers got their hands on three illegal versions, they found that the counterfeit drugs had low-purity semaglutide, had dosages that exceeded the labeled amount, and one had signs of bacterial contamination

In the most recent GFAPS wave, nearly 20% of respondents said that they have not yet used the drugs, but they are considering using them this year

Well walk through each one in turn